Paul Alloway - 01 Jan 2023 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Chief Legal Officer and Secretary Exhibit 24 - Power of Attorney
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Paul Alloway
Issuer symbol
QTTB
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:32:23 UTC
Previous filing
11 Mar 2022
Next filing
20 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Options Exercise +4,290 +31% 17,913 01 Jan 2023 Direct F1, F2
transaction FIXX Common Stock Options Exercise +5,280 +29% 23,193 01 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Restricted Stock Units Options Exercise $0 -4,290 -49% $0.000000 4,420 01 Jan 2023 Common Stock 4,290 Direct F1, F3
transaction FIXX Restricted Stock Units Options Exercise $0 -5,280 -33% $0.000000 10,720 01 Jan 2023 Common Stock 5,280 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 Includes 3,397 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2022.
F3 The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one half of the RSUs on each of January 1, 2023 and January 1, 2024. The RSUs do not have an expiration date.
F4 The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.

Remarks:

Chief Legal Officer and Secretary Exhibit 24 - Power of Attorney